January 3, 2020 Alex Hogan/STAT
A nd so, another working week will soon draw to a close. A little quicker than usual, though, yes? Nonetheless, this is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is decidedly modest. We hope to catch up on some reading, run some errands, and take a few strolls about town. And what about you? This is a fine time play catchup yourself, now that the end-of-year festivities have come and gone. This may also be an opportunity to get organized for what may be a busy month. Or perhaps reach out to someone you may have missed recently. Well, whatever you do, have a grand time. But be safe. Enjoy, and see you soon.
More drugs are approved in December than any other time of year — but the burst of activity has an unintended side effect: The end-of-year approvals are later associated with more hospitalizations, life-threatening events, and deaths , The Wall Street Journal writes, citing a new study. In the U.S., the number of December drug approvals is roughly 80% larger than in any other month. The surges are not driven by explicit deadlines, leading the researchers to suspect the increases are motivated by self-imposed “desk-clearing” benchmarks.
Also in Industry News
How to decide whether or not to start treatment for prostate cancer?
Analysis of the SARS-CoV-2 proteome via visual tools
$65m investment increases British Patient Capital’s exposure to life sciences and health technology